TrialDrugs in R&D2018

A Phase I Study of the Pharmacokinetics and Pharmacodynamics of Intranasal Doxylamine in Subjects with Chronic Intermittent Sleep Impairment.

Mark Allison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.